Spinal cord injury (SCI) is associated with high production and excessive accumulation of pathological 4-hydroxy-trans-2-nonenal (4-HNE), a reactive aldehyde, formed by SCI-induced metabolic dysregulation of membrane lipids. Reactive aldehyde load causes redox alteration, neuroinflammation, neurodegeneration, pain-like behaviors, and locomotion deficits. Pharmacological scavenging of reactive aldehydes results in limited improved motor and sensory functions. In this study, we targeted the activity of mitochondrial enzyme aldehyde dehydrogenase 2 (ALDH2) to detoxify 4-HNE for accelerated functional recovery and improved pain-like behavior in a male mouse model of contusion SCI. N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide (Alda-1), a selective activator of ALDH2, was used as a therapeutic tool to suppress the 4-HNE load. SCI was induced by an impactor at the T9–10 vertebral level. Injured animals were initially treated with Alda-1 at 2 hours after injury, followed by once-daily treatment with Alda-1 for 30 consecutive days. Locomotor function was evaluated by the Basso Mouse Scale, and pain-like behaviors were assessed by mechanical allodynia and thermal algesia. ALDH2 activity was measured by enzymatic assay. 4-HNE protein adducts and enzyme/protein expression levels were determined by western blot analysis and histology/immunohistochemistry. SCI resulted in a sustained and prolonged overload of 4-HNE, which parallels with the decreased activity of ALDH2 and low functional recovery. Alda-1 treatment of SCI decreased 4-HNE load and enhanced the activity of ALDH2 in both the acute and the chronic phases of SCI. Furthermore, the treatment with Alda-1 reduced neuroinflammation, oxidative stress, and neuronal loss and increased adenosine 5′-triphosphate levels stimulated the neurorepair process and improved locomotor and sensory functions. Conclusively, the results provide evidence that enhancing the ALDH2 activity by Alda-1 treatment of SCI mice suppresses the 4-HNE load that attenuates neuroinflammation and neurodegeneration, promotes the neurorepair process, and improves functional outcomes. Consequently, we suggest that Alda-1 may have therapeutic potential for the treatment of human SCI. Animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of MUSC (IACUC-2019-00864) on December 21, 2019.

Mushfiquddin Khan

Department of Pediatrics,Medical University of South Carolina,Charleston,SC,USA;Department of Pathology and Laboratory Medicine,Medical University of South Carolina,Charleston,SC,USA;Ralph H.Johnson VA Medical Center,Charleston,SC,USA

中国神经再生研究（英文版）

[1]Mushfiquddin Khan-.Neuroprotective effects of Alda-1 mitigate spinal cord injury in mice: involvement of Alda-1-induced ALDH2 activation-mediated suppression of reactive aldehyde mechanisms)[J].中国神经再生研究（英文版）,2022(01):185-193

detoxify,benzodioxol,dichlorobenzamide,Injured,algesia,neurorepair,MUSC

Neuroprotective,effects,Alda,mitigate,spinal,cord,injury,mice,involvement,induced,ALDH2,activation,mediated,suppression,reactive,mechanisms,Spinal,SCI,associated,high,production,excessive,accumulation,pathological,hydroxy,trans,nonenal,HNE,formed,by,metabolic,dysregulation,membrane,lipids,Reactive,causes,redox,alteration,neuroinflammation,neurodegeneration,pain,like,behaviors,locomotion,deficits,Pharmacological,scavenging,aldehydes,results,limited,improved,sensory,functions,this,study,targeted,activity,mitochondrial,enzyme,dehydrogenase,accelerated,functional,recovery,male,mouse,model,contusion,ylmethyl,selective,activator,was,used,therapeutic,tool,impactor,T9,vertebral,animals,were,initially,treated,hours,after,followed,once,daily,treatment,consecutive,days,Locomotor,evaluated,Basso,Mouse,Scale,assessed,mechanical,allodynia,thermal,measured,enzymatic,assay,protein,adducts,expression,levels,determined,western,blot,analysis,histology,immunohistochemistry,resulted,sustained,prolonged,overload,which,parallels,decreased,enhanced,both,acute,chronic,phases,Furthermore,reduced,oxidative,stress,neuronal,loss,increased,adenosine,triphosphate,stimulated,process,locomotor,Conclusively,provide,evidence,that,enhancing,suppresses,attenuates,promotes,improves,outcomes,Consequently,suggest,may,have,potential,human,Animal,procedures,approved,Institutional,Care,Use,Committee,IACUC,December

0.530542